Priority Date: 14.10.11 (US 201161547637P)

HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES

  • Application ID: EP12780613
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1262.69
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Jones Day is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.10.2011 - Priority Date (US 201161547637P)
  • 18.04.2013 - Publication A2 (WO2013056070)
  • 20.08.2014 - Publication A2 (EP2766359)
  • 13.04.2016 - Publication B1 (EP2766359)
  • 05.04.2017 - Publication B9 (EP2766359)